Skip to content

The evaluation for the diagnostic efficacy of serum markers of bone turnover in the primary osteoporosis

The evaluation for the diagnostic efficacy of serum markers of bone turnover in the primary osteoporosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-15006363
Enrollment
Unknown
Registered
2015-05-05
Start date
2015-05-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary osteoporosis

Interventions

Gold Standard:
Index test:

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnosis of primary osteoporosis; 2. Women, from 45 to 65 years old; 3. The patients accept the plan, and agree on the laboratory examination (for example, bone turnover markers,liver and kidney function, blood sugar and so on); 4. The patients sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. metabolic bone disease around the body; 2. Fracture by traumatic injuries in two years; 3. Chronic diseases affecting bone metabolism, including diabetes, rheumatoid arthritis, hyperparathyroidism, hyperthyroidism and other chronic diseases that require long-term treatment; 4. Severe heart and brain vessels diseases; 5. Liver and kidney dysfunction; 6. Chronic gastrointestinal diseases; 7. Acute or chronic infection in the near future; 8. Strenuous exercise in two or three days; 9. Serious organic disease, mental and nervous system diseases, and active osteoarthropathy; 10. The patients who have taken estrogen and calcitonin, or fluoride, bisphosphonates,adrenocortical hormone in one year.

Design outcomes

Primary

MeasureTime frame
procollagen 1 N-terminal propeptid;cross linked C-telopeptide of type 1 collagen;bone mineral density;

Countries

China

Contacts

Public ContactRanxing Zhang
bjzrx@sina.com+86 13601223168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026